#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia refractory Arrhythmia Neurodegenerative disorder Pemphigus Acute on chronic liver failure Arteriosclerosis Renal cell carcinoma Soft tissue sarcoma Mitochondrial encephalomyopathy Orthostatic hypotension Autoinflammation with infantile enterocolitis Ovarian cancer Guillain-Barre syndrome Partial lipodystrophy Short stature More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome Rosai-Dorfman syndrome – Trials in Disease Hypereosinophilic syndrome – Diagnostics Alagille syndrome – Trials in Disease Marfan’s syndrome – Basic Information Short-bowel syndrome – Diagnostics Haemophilia A with anti factor VIII – Basic Information Pemphigoid – Treatment Rosai-Dorfman syndrome – Treatment Myelodysplastic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Granisetron Xp-Dc+Tl+Klh Citric Acid Retinol Acetate Inaxaplin Ipn01194 Paeonol INSULIN DEGLUDEC Calcitriol Nemvaleukin Alfa Tianeptine Sodium ULEFNERSEN Gliquidone Tipranavir Dactylis Glomerata DIMENHYDRINATE Cdr132L Cariprazine Hydrochloride Roflumilast Macrogol 3350 More therapies…

    Learn about Your Condition

    Asplenia Cardiac arrest Hairy cell leukaemia ROHHAD syndrome Pancreatitis chronic Endometrial adenocarcinoma Hot flush Hidradenitis Acarodermatitis Gastrooesophageal cancer Mitochondrial DNA depletion Fracture infection Myocarditis post infection Porphyria non-acute Diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study of RLY-2608 for Adults and Children with PIK3CA-Related Overgrowth and Malformations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lymphatic malformation
    • PIK3CA-activated mutation
    • PIK3CA related overgrowth spectrum
    Investigated Drugs:
    • RLY-2608
    Belgium France Germany Ireland Italy Norway +1

  • Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Croatia Czechia France Germany Ireland Italy +2

  • Study on the Safety and Effects of CRD-4730 for Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

    Recruiting

    2 1
    Investigated Diseases:
    • Ventricular tachycardia
    Investigated Drugs:
    • Crd-4730
    France Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • ATUMELNANT
    Germany Italy

  • Study of N-Acetyl-L-Leucine in Patients with Ataxia-Telangiectasia: A Phase III Trial

    Recruiting

    3 1
    Investigated Diseases:
    • Ataxia telangiectasia
    Investigated Drugs:
    • L-Acetylleucine
    Germany Slovakia Spain

  • Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Prader-Willi syndrome
    Belgium Czechia Denmark France Germany Italy +4
Previous Page
1 … 5 6 7 8 9 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!